Influenza a virus - A model for viral antigen presentation to cytotoxic T lymphocytes

Seminars in Virology

Volumn 7, Issue 1, 1996, Pages 61-73

  Parker, Claire E ^a,b   Gould, Keith G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antigen processing; CTL; Influenza; Virus evolution

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PROTEIN PROCESSING; REVIEW; VIRUS IMMUNITY;

EID: 0029863557     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0008     Document Type: Article

References (114)

1. Kingsbury D (1990) Orthomyxoviridae and their replication, in Virology (Fields BN, Knipe DM, eds) Chapter 39. Raven Press, New York
2. Murphy BR, Webster RG (1990) Orthomyxoviruses, in Virology Vol.1 (Fields BN, Knipe DM, eds) Chapter 40. Raven Press, New York
3. Gorman OT, Bean WJ, Webster RG (1992) Evolutionary processes in influenza-viruses: divergence, rapid evolution, and stasis. Curr Top Microbiol Immunol 176:75-97
4. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179
5. Webster RG, Laver WG, Air GM, Schild GC (1982) Molecular mechanisms of variation in influenza viruses. Nature 296:115-121
6. Smith FI, Palese P (1989) Variation in influenza virus genes, in The Influenza Viruses (Krug R, eds) Ch. 7. Plenum Press, New York
7. Young JF, Palese P (1979) Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc Natl Acad Sci USA 76:6547-6551
8. Holland JJ, Delatorre JC, Steinhauer DA (1992) RNA virus populations as quasi-species. Curr Top Microbiol Immunol 176:1-20
9. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong-Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 289:373-378
10. Fitch WM, Leiter JM, Li XQ, Palese P (1991) Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci USA 88:4270-4274
11. Yewdell JW, Webster RG, Gerhard WU (1979) Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279:246-248
12. Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ (1994) Neutralization escape mutants of type-A influenza-virus are readily selected by antisera from mice immunized with whole virus - a possible mechanism for antigenic drift. J Gen Virol 75:3493-3502
13. Pyhala R, Ikonen N, Forsten T, Alanko S, Kinnunen L (1995) Evolution of the HA1 domain of human influenza A (H1N1) virus: loss of glycosylation sites and occurrence of herald and conserved strains. J Gen Virol 76:205-210
14. Schild GC, Oxford JS, DeJong JC, Webster RG (1983) Evidence for host-cell selection of influenza-virus antigenic variants. Nature 303:706-709
15. Herlocher ML, Bucher D, Webster RG (1992) Host range determination and functional mapping of the nucleoprotein and matrix genes of influenza-viruses using monoclonal-antibodies. Virus Res 22:281-293
16. Nakajima K, Nobusawa E, Nakajima S (1990) Evolution of the NS genes of the influenza A viruses. II. Characteristics of the amino acid changes in the NS1 proteins of the influenza A viruses. Virus Genes 4:15-26
17. Roch a E, Cox NJ, Black RA, Harmon MW, Harrison CJ, Kendal AP (1991) Antigenic and genetic-variation in influenza-A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol 65:2340-2350
18. Yewdell JW, Hackett CJ (1989) The specificity and function of T lymphocytes induced by Influenza A virus, in The Influenza Viruses (Krug RM, ed.) p 61. Plenum Press, New York
19. McMichael AJ (1994) Cytotoxic T lymphocytes specific for influenza virus. Curr Top Microbiol and Immunol 189:75-91
20. Lin YL, Askonas BA (1981) Biological properties of an influenza-A virus-specific killer T-cell clone - inhibition of virus-replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 154:225-234
21. Man S, Newberg MH, Crotzer VL, Luckey CJ, Williams NS, Chen Y, Huczko EL, Ridge JP, Engelhard VH (1995) Definition of a human T-cell epitope from influenza-A non structural protein-1 using HLA-A2.1 transgenic mice. Int Immunol 7:597-605
22. Bennink JR, Yewdell JW, Smith GL, Moss B (1986) Anti-influenza cytotoxic T lymphocytes recognise three viral polymerases and a non-structural protein: responsiveness to individual viral antigens is MHC controlled. J Virol 61:1098-1102
23. Yewdell JW, Bennink JR, Smith GL, Moss B (1985) Influenza A virus nucleoprotein is a major target for cross-reactive anti-influenza virus specific cytotoxic T lymphocytes. Proc Natl Acad Sci USA 89:1785-1789
24. Young A, Nathenson SG, Sacchettini JC (1995) Structural studies of class-I major histocompatibility complex proteins - insights into antigens presentation. Faseb 9:26-36
25. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee HG (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T-cells. Nature 348:252-254
26. Vanbleek GM, Nathenson SG (1990) Isolation of an endogenously processed immunodominant viral peptide from the class-I H-2Kb molecule. Nature 348:213-216
27. Falk K, Rotzsche O, Stevanovic S, Jung G, Rammensee HG (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296
28. Rammensee HG (1995) Chemistry of peptides associated with MHC class-I and class-II molecules. Curr Opin Immunol 7:85-96
29. Cossins J, Gould KG, Smith M, Driscoll P, Brownlee GG (1993) Precise prediction of a K(k)-restricted cytotoxic T-cell epitope in the NS1 protein of influenza-virus using an MHC allele-specific motif. Virology 193:289-295
30. Dibrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE (1993) HLA-A1 and HLA-A3 T-cell epitopes derived from influenza-virus proteins predicted from peptide binding motifs. J Immunol 151:5930-5935
31. Yewdell JW, Bennink JR (1992) Cell biology of antigen-processing and presentation to major histocompatibility complex class-I molecule-restricted T-lymphocytes. Adv Immunol 52:1-123
32. Howard JC (1995) Supply and transport of peptides presented by class 1 MHC molecules. Curr Opin Immunol 7:69-76
33. Rivett AJ (1993) Proteasomes - multicatalytic proteinase complexes. Biochem J 291:1-10
34. Monaco JJ (1992) A molecular-model of MHC class-I-restricted antigen processing. Immunol Today 13:173-178
35. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL (1994) Inhibitors of the proteasome block the degradation of most cell-proteins and the generation of peptides presented on MHC class-I molecules. Cell 78:761-771
36. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL (1993) A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552-554
37. Vankaer L, Ashtonrickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S (1994) Altered peptidase and viral-specific T-cell response in Lmp2 mutant mice. Immunity 1:533-554
38. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, VonBoehmer H (1994) MHC class-I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234-1237
39. Sibille C, Gould KG, Willard-Gallo K, Rivett AJ, Powis S, Butcher GW, De Baetseleir P (1995) LMP2+ proteosomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr Biol 5:923-930
40. Lowe J, Stock D, Jap R, Zwickl P, Baumeister W, Huber R (1995) Crystal-structure of the 20s proteasome from the archaeon t- acidophilum at 3.4-angstrom resolution. Science 268:533-539
41. Townsend A, Trowsdale J (1993) The transporters associated with antigen presentation. Semin Cell Biol 4:53-61
42. Schumacher T, Kantesaria DV, Heemels MT, Ashtonrickardt PG, Shepherd JC, Fruh K, Yang Y, Peterson PA, Tonegawa S, Ploegh HL (1994) Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179:533-540
43. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, Neefjes JJ (1994) Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648-651
44. Neisig A, Roelse J, Sijts AJA, Ossendorp F, Feltkamp MCW, Kast WM, Melief CJM, Neefjes JJ (1995) Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J Immunol 154:1273-1279
45. Snyder HL, Yewdell JW, Bennink JR (1994) Trimming of antigenic peptides in an early secretory compartment. J Exp Med 180:2389-2394
46. Elliott T, Willis A, Cerundolo V, Townsend A (1995) Processing of major histocompatibility class-I - restricted antigens in the endoplasmic-reticulum. J Exp Med 181:1481-1491
47. Ortmann B, Androlewicz MJ, Cresswell P (1994) MHC class I/beta(2)-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864-867
48. Suh WK, Cohendoyle MF, Fruh K, Wang K, Peterson PA, Williams DB (1994) Interaction of MHC class-I molecules with the transporter associated with antigen-processing. Science 264:1322-1326
49. Wraith DC (1987) The recognition of influenza A virus-infected cells by cytotoxic T lymphocytes. Immunol Today 8:239-246
50. Townsend ARM (1987) Recognition of influenza virus proteins by cytotoxic T lymphocytes. Immunol Res 6:80-100
51. Zweerink HJ, Courtneidge SA, Skehel JJ, Crumpton MJ, Askonas BA (1977a) Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature 267:354-356
52. Doherty PC, Effros RB, Bennink J (1977) Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc Natl Acad Sci USA 74:1209-1213
53. Effros RB, Doherty PC, Gerhard W, Bennink J (1977) Generation of both crossreactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med 145:557-568
54. Kees U, Krammer PH (1984) Most influenza A virus specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J Exp Med 159:365-377
55. Zweerink HJ, Askonas BA, Millican D, Courtneidge SA, Skehel JJ (1977b) Cytotoxic T cells to type A Influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity. Eur J Immunol 7:630-635
56. Frentzel S, Kuhnhartmann I, Gernold M, Seelig A, Kloetzel PM (1993) The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7 - evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular-levels of both messenger-RNA and LMP-containing 20s-proteasomes are differentially regulated. Eur J Biochem 216:119-126
57. Townsend A, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ (1986) The epitopes of influenza nucleoprotein recognized by cyto-toxic T-lymphocytes can be defined with short synthetic peptides. Cell 44:959-968
58. Culmann B, Gomard E, Kieny MP, Guy B, Dreyfus F, Saimot AG, Sereni D, Sicard D, Levy JP (1991) Six epitopes reacting with human cytotoxic CD8+ T-cells in the central region of the HIV-1 nef protein. J Immunol 146:1560-1565
59. Parker CE, Nighingale S, Taylor GP, Weber J, Bangham CRM (1994) Circulating anti-Tax cytotoxic T-lymphocytes from Human T-cell Leukemia-virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 68:2860-2868
60. Tussey LG, Rowland-Jones S, Zheng TS, Androlewicz MJ, Cresswell P, Frelinger JA, McMichael AJ (1995) Different MHC Class Alleles compete for presentation of overlapping viral epitopes. Immunity 3:65-77
61. Braciale TJ, Braciale VL, Winkler M, Stroynowski I, Hood L, Sambrook J, Gething MJ (1987) On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med 166:678-692
62. Hammond SA, Johnson RP, Kalams SA, Walker BD, Takiguchi M, Safrit JT, Koup RA, Siliciano RF (1995) An epitope-selective, transporter associated with antigen presentation (TAP)-1/ 2-independent pathway and a more general TAP-1/ 2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8(+) CTL. J Immunol 154:6140-6156
63. Nijman HW, Houbiers JGA, Vierboom MPM, Vanderberg SH, Drijfhout JW, Damaro J, Kenermans P, Melief CJM, Kast WM (1993) Identification of peptide sequences that potentially trigger HLA- A2.1-restricted cytotoxic T-lymphocytes. Eur J Immunol 23:1215-1219
64. Martinon F, Gomard E, Hannoun C, Levy JP (1990) In vitro human cytotoxic T-cell responses against influenza-A virus can be induced and selected by synthetic peptides. Eur J Immunol 20:2171-2176
65. Enami M, Palese P (1991) High-efficiency formation of influenza-virus transfectants. J Virol 65:2711-2713
66. Isobe H, Moran T, Li SQ, Young A, Nathenson S, Palese P, Bona C (1995) Presentation by a major histocompatibility complex class-I molecule of nucleoprotein peptide expressed in 2 different genes of an influenza-virus transfectant. J Exp Med 181:203-213
67. + T-cells. J Exp Med 174:875-880
68. Bender BS, Croghan T, Small PA (1992) Transgenic mice lacking class-I (CD8+) cytotoxic lymphocytes-T (CTL) have delayed recovery and increased mortality following viral challenge. Clin Res 40:247A
69. McMichael AJ, Gotch F, Cullen P, Askonas B, Webster RG (1981) The human cytotoxic Y-cell response to influenza-A vaccination. Clin Exp Immunol 43:276-284
70. McMichael AJ, Askonas BA (1978) Influenza virus specific cytotoxic T cells in man; induction and properties of the cytotoxic T cell. Eur J Immunol 8:705-710
71. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937
72. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM (1990) Viral escape by selection of cytotoxic T-cell-resistant virus variants in vivo. Nature 346:629-633
73. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H (1991) In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T-lymphocytes. Proc Natl Acad Sci USA 88:11047-11051
74. Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MBA (1995) CTL escape viral variants. 1. Generation and molecular characterization. Virology 210:29-40
75. Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T-cell receptor antagonists of major histocompatibility complex class-I restricted cytotoxic T-cells. J Exp Med 177:1541-1550
76. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ (1994) Cytotoxic T-cell activity antagonized by naturally-occurring HIV-1 gag variants. Nature 369:403-407
77. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, Decarli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410
78. Gournier H, Pascolo S, Siegrist CA, Jehan J, Perarnau B, Garcia Z, Rose T, Neefjes J, Lemmonier FA (1995) Restriction of self-antigen presentation to cytolytic T-lymphocytes by mouse peptide pumps. Eur J Immunol 25:2019-2026
79. Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH (1991) Efficient processing of an antigenic sequence for presentation by MHC class-I molecules depends on its neighboring residues in the protein. Cell 66:1145-1153
80. Cerundolo V, Tse AGD, Salter RD, Parham P, Townsend A (1991) CD8 independence and specificity of cytotoxic T-lymphocytes restricted by HLA Aw68.1. Proc Roy Soc Lond Series B Biol Sci 244:169-177
81. Ye ZP, Baylor NW, Wagner RR (1989) Transcription-inhibition and RNA-binding domains of influenza-A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol 63:3586-3594
82. Smeenk CA, Brown EG (1994) The influenza-virus variant A/ FM/ 1/ 47-MA possesses single amino-acid replacements in the hemagglutinin, containing virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68:530-534
83. Cox NJ, Kitame F, Kendal AP, Maassab HF, Naeve C (1989) Identification of sequence changes in the cold-adapted live attenuated influenza vaccine strain, A/ Arbour/ 6/ 60 (H2N2). Virology 167:554-567
84. Xu XY, Kilbourne ED, Hall HE, Cox NJ (1994) Non-immunoselected intrastrain genetic-variation detected in pairs of high-yielding influenza-A (H3N2) vaccine and parental viruses. J Inf Dis 170:1432-1438
85. Kawaoka Y, Krauss S, Webster RG (1989) Avian-to-human transmission of the PB1 gene of influenza-A viruses in the 1957 and 1968 pandemics. J Virol 63:4603-4608
86. Moss P, Moots RJ, Rosenberg WMC, Rowland-Jones SJ, Bodmer HC, McMichael AJ, Bell JI (1991) Extensive conservation of alpha-chain and beta chain of the human T-cell antigen receptor recognizing HLA-A2 and influenza-A matrix peptide. Proc Natl Acad Sci USA 88:8987-8990
87. Bowness P, Moss PAH, Rowland-Jones S, Bell JI, McMichael AJ (1993) Conservation of T-cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T-lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class-I-restricted responses. Eur J Immunol 23:1417-1421
88. Engblom E, Ekfors TO, Meurman OH, Toivanen A, Nikoskelainen J (1983) Fatal influenza-A myocarditis with isolation of virus from the myocardium. Act Med Scand 213:75-78
89. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC (1991) Identification of self peptides bound to purified HLA-B27. Nature 353:326-329
90. Shu LL, Bean WJ, Webster RG (1993) Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990. J Virol 67:2723-2729
91. Spicer CC (1979) Mathematical modelling of influenza epidemics. Brit Med Bull 35:23-28
92. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koppe B, Sigmund K, Bangham CRM, McMichael AJ (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611
93. Tripp RA, Hou S, McMickle A, Houston J, Doherty PC (1995) Recruitment and proliferation of CD8(+) T-cells in respiratory virus-infections. J Immunol 154:6013-6021
94. Bean WJ, Schell M, Katz J, Kawaoka Y, Naeve C, Gorman O, Webster RG (1992) Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol 66:1129-1138
95. Ortin J, Martinez C, del Rio L, Davila M, Lopez-Galindez C, Villenueva N, Domingo E (1983) Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype. Gene 23:233-239
96. Buonagurio DA, Nakada S, Parvin JD, Krystal M, Palese P, Fitch WM (1986) Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science 232:980-982
97. Gorman OT, Donis RO, Kawaoka Y, Webster RG (1990) Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol 64:4893-4902
98. Hayashida H, Toh H, Kikuno R, Miyata T (1985) Evolution of influenza-virus genes. Mol Biol Evol 2:289-303
99. Sweetser MT, Braciale VL, Braciale TJ (1989) Class-I major histocompatibility complex-restricted lymphocyte-T recognition of the influenza hemagglutinin - overlap between class-I cyto-toxic lymphocytes-T and antibody sites. J Exp Med 170:1357-1368
100. Cao W, Myers-Powell BA, Braciale TJ (1994) Recognition of an immunoglobulin VH epitope by influenza virus-specific class 1 major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 179:195-202
101. Gould KG, Scotney H, Brownlee GG (1991) Characterization of 2 distinct major histocompatibility complex class-I Kk-restricted T-cell epitopes within the influenza A/ PR/ 8/ 34 virus hemagglutinin. J Virol 65:5401-5409
102. Sweetser MT, Morrison LA, Braciale VL, Braciale TJ (1989) Recognition of pre-processed endogenous antigen by class-I but not class-II MHC-restricted T-cells. Nature 342:180-182
103. Kuwano K, Braciale TJ, Ennis FA (1989) Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol 2:163-173
104. Falk K, Fotzchke O, Deres K, Metzger J, Jung G, Rammensee HG (1991) Identification of naturally processed viral non-apeptides allows their quantification in infected-cells and suggests an allele-specific T-cell epitope forecast. J Exp Med 174:425-434
105. Bastin J, Rothbard J, Davey J, Jones I, Townsend A (1987) Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class-I-restricted cyto-toxic T-lymphocytes. J Exp Med 165:1508-1523
106. Taylor PM, Davey J, Howland K, Rothbard JB, Askonas BA (1987) Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics 26:267-272
107. Wysocka M, Eisenlohr LC, Otvos L, Horowitz D, Yewdell JW, Bennink JR, Hackett CJ (1994) Identification of overlapping class-I and class-II H-2(d)-restricted T-cell determinants of influenza-virus N1 neuraminidase that require infectious virus for presentation. Virology 201:86-94
108. Silver ML, Guo HC, Strominger JL, Wiley DC (1992) Atomic-structure of a human MHC molecule presenting an influenza-virus peptide. Nature 360:367-369
109. McMichael AJ, Gotch FM, Rothbard J (1986) HLA-B37 determines an influenza-A virus nucleoprotein epitope recognized by cyto-toxic T-lymphocytes. J Exp Med 164:1397-1406
110. Sutton J, Rowland-Jones S, Rosenberg W, Nixon D, Gotch F, Gao XM, Murray N, Spoonas A, Driscoll P (1993) A sequence pattern for peptides presented to cytotoxic T-lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol 23:447-453
111. Huet S, Nixon DF, Rothbard JB, Townsend ARM, Ellis SA, McMichael AJ (1990) Structural homologies between 2 HLA B27-restricted peptides suggest residues for interaction with HLA-B27. Int Immunol 2:311-316
112. Morrison J, Elvin J, Latron F, Gotch F, Moots R, Strominger JL, McMichael AJ (1992) Identification of the nonamer peptide from influenza-A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T-lymphocytes. Eur J Immunol 22:903-907
113. Bednarek MA, Sauma SY, Gammon MC, Porter G, Tanhankar S, Williamson AR, Zweerink HJ (1991) The minimum peptide epitope from the influenza-virus matrix protein - extra and intracellular loading of HLA-A2. J Immunol 147:4047-4053
114. Dong T, Boyd D, Rosenberg W, Alp N, Takiguchi M, McMichael AJ, Rowland-Jones (1995) Increased affinity for HLA-B35 of an influenza A epitope modified at an 'anchor' residue results in an antagonistic peptide. Eur J Immunol (submitted)